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Rho GTPases of the Ras superfamily have important roles in regulating the organization of the actin filament system,
morphogenesis and migration of cells. Structural details for these proteins are still emerging, and information on their
dynamics in solution is much needed to understand the mechanisms underlying their signaling functions. This report
reviews conditions for solution NMR studies of Rho GTPases and describes our optimization and stabilization of Rnd1 for
such experiments. Rnd1 belongs to the Rnd protein subfamily branch of Rho small GTPases and functions in neurite
outgrowth, dendrite development and in axon guidance. However, as we report here, solution NMR studies of this
protein are challenging. Multiple methods have been employed to enhance the stability of Rnd1, including by cleavage
of an N-terminal His expression tag and by addition of non-hydrolysable GMPPNP (b: c-imidoguanosine 5'-triphosphate)
nucleotide. Further stabilization of Rnd1 against aggregation was achieved through a structure informed point mutation
while maintaining its conformation and binding affinity for a partner protein. The NMR spectrum of the optimized
protein reveals significant improvement in NMR signal dispersion and intensity. This work paves the way for structural
and protein-protein/protein-ligand interaction studies of Rnd1 by solution NMR and also provides a guide for
optimization and stabilization of other Rho GTPases.
Introduction
Rho GTPases of the Ras superfamily regulate diverse cellular and
developmental events including cell morphology, cell to cell
interaction, cell migration and adhesion.
1,2 Abnormalities in Rho
GTPase function have vital consequences on the reorganization
of actin cytoskeleton, such as an increase in cell migration seen
in cell metastasis and tissue invasion that are part of cancer
progression.
3,4 Of the 22 vetebrate Rho GTPases, the structures of
12 have been determined by X-ray crystallography, in part due to
intensive efforts by the Structure Genomics Consortium. Often
structures are available for the inactive (GDP bound) as well as
for the active (GTP bound) form, although in the latter the
nucleotide is typically exchanged by a non-hydrolysable analog,
such as GMPPNP or GTPcS. So far only three Rho GTPases,
i.e., Cdc42,
5-12 Rac1,
13-18 RhoA,
19-21 have been extensively studied
by solution NMR. A summary of the expression and purification
of these proteins, as well as the concentration and buffer condition
of the NMR samples, is given in Table 1 and is further discussed
at the end of the paper (section 3.7). All three proteins give high
quality spectra under appropriate conditions. It is possible that the
GTPases that have been most widely utilized in biological settings
are also the ones that are the most well behaved in solution. NMR
studies of other Rho GTPases could be more challenging, as this
report on the optimization and stabilization of Rnd1 for solution
NMR illustrates.
Rnd1 is one of three Rnd proteins, Rnd1, Rnd2 and RhoE/
Rnd3, which are a subset of the Rho family. Rnd proteins exhibit
unusual properties in that they bind but (with possible exception
of Rnd2) do not hydrolyze GTP (guanosine triphosphate) at an
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appreciable rate. Multiple functions have been revealed for Rnd1,
such as its role in the regulation of neurite outgrowth, dendrite
development, and axon guidance.
22-24 Lately, a crystal structure
was solved for Rnd1 (pdb id: 2CLS) and of several of its com-
plexes with an effector of interest, the Rho GTPase binding
domain of plexin.
25,26 This provided important structural insights
for this protein, but further studies are needed in order to
understand the structure-dynamics-function relationship of Rnd1
and how the protein participates in cell signaling mechanisms.
Solution NMR spectroscopy has become a versatile and key tool
for the characterization of protein structure in solution, protein
dynamics and also for the delineation of biomolecular interac-
tions.
27,28 For example, NMR relaxation measurements suggest an
allosteric mechanism for cell signaling when plexin is bound to
the Rho GTPase, and Rnd1 homolog, Rac1.
14 Compared to Rac1
thermodynamic measurements and molecular dynamics simula-
tions also reveal a likely different model for Rnd1 GTPase binding.
18
By contrast to the three Rho GTPases studied previously by
solution NMR, this is the first direct study of Rnd1 by NMR and
we found this protein more challenging to work with. This is due
to several problematic features, such as its relative long-term
instability and its tendency to aggregate. Similar problems
were not reported in the crystallization of the protein or its
complexes;
25 however, the crystallization conditions are far from
physiological. We utilized multiple approaches to address these
problems for solution NMR; specifically, we combined the
cleavage of the His tag with the screening of buffer conditions and
introduction of point mutations in the protein.
29-32 Previously, we
Table 1. Summary of protein expression, purification, concentrations and buffer condition of Rho GTPases Cdc42, Rac1, RhoA and Rnd1
Rho GTPase
a Description/
[Reference]
expression protein
concentraton
temp buffer
Cdc42 Cdc42-GDP Cdc42-
GMPPCP[5,6] Cdc42-
GTPcS [7]
1-187, GST tagged (GST cleaved
after purification, leaving
GSLSLIISA-N-terminal addition)
0.8 mM 25°C 5 mM Na.phosphate buffer (pH 5.5),
b
25 mM NaCl, 5 mM MgCl2, 1 mM NaN3
Cdc42
(T35A)
active switch mutant
of Cdc42[8,9]
1-187, His6-tagged (His6
cleaved after purification)
0.2–0.5 mM 25°C 10 mM Na.phosphate buffer (pH 5.5),
b
25 mM NaCl, 5 mM MgCl2, and 1 mM NaN3
Cdc42
(F28L)
Cdc42-GDP [9] 1-187, His6-tagged (His6
cleaved after purification)
0.2–0.5mM 25°C 10 mM Na.phosphate buffer (pH 5.5),
b
25 mM NaCl, 5 mM MgCl2, and 1 mM NaN3
Cdc42 (Q61L,
ACK bound)
Cdc42-GMPPNP [10] 1-184, His6-tagged (His6
cleaved after purification)
~1 mM 5 mM Na.phosphate buffer (pH 5.5), 25 mM
NaCl, 5 mM MgCl2, 5 mM DTT, 1mM GMPPNP
Cdc42 (WASP
bound)
Cdc42-GMPPCP [11] 1-179, untagged ~1 mM 25°C 25 mM Na.phosphate buffer (pH 5.5),
25 mM NaCl, 5 mM MgCl2, 5 mM DTT
Cdc42 (Q61L,
PAK bound)
Cdc42-GMPPNP [10] 1-184, His6-tagged (His6
cleaved after purification)
~1 mM 25–30°C 5 mM Na.phosphate buffer (pH 5.5),
25 mM NaCl, 5 mM MgCl2, 5 mM DTT
Cdc42
(SoPE2 bound)
Cdc42-GDP [12] 1-184, His6-tagged (His6
cleaved after purification)
1.3 mM 20 mM Na.phosphate buffer (pH 5.5),
50 mM NaCl
Rac1 Rac1-GDP [13] residues 1-188, C178S, no tag 0.5–0.7 mM 25°C 50 mM Tris maleate buffer (pH 6.8),
50 mM NaCl, 20 mM MgCl2, 10 mM DTT,
0.1 mM GDP, 0.1% sodium azide
Rac1-GMPPNP [14] residues 1-184, C178S, no tag 0.8 mM 25°C “physiological buffer” (pH 6.8), 4 mM DTT,
4 mM MgCl2
Rac1 (Q61L,
PRK1 bound)
Rac1-GTP [15] residues 1-191, GST-tag
(cleaved after purification)
1 mM 25°C 20 mM Tris-HCL (pH 7.4) 20mM NaCl,
Rac1 (RhoGDI
bound)
Rac1-GDP [16] Residues 1-191 no tag 0.3 mM 15°C 50 mM Na.phosphate buffer (pH 6.3),
50 mM NaCl, 1 mM DTT, 5mM MgCl2
Rac1 (Q61L
Plexin RBD bound)
Rac1-GTP [17,18] residues 1-184, C178S,
no tag or His6-tag
1 mM and vars.
ratios
25°C 50 mM Na.phosphate buffer (pH 6.8),
50 mM NaCl, 1 mM DTT, 5mM MgCl2
RhoA RhoA-GDP [19]
RhoA-GTPcS
residues 1–181, His6-tag
(cleaved after purification)
0.3 mM 20°C 20 mM HEPES buffer (pH7.0), 100 mM NaCl,
5 mM MgCl2, 2 mM TCEP
RhoA-GDP [20] residues 1–181, His6-tagged 0.9 mM 25°C 25 mM Tris-HCl buffer (pH 7.5), 50 mM NaCl,
5 mM MgCl2, 1 mM DTT
RhoA (DH-PH
bound)
RhoA-nucleotide
free [21]
residues 1–181, His6-tagged 0.3 mM 25°C 200 mM MOPS/Tris buffer (pH 7.5), 1 mM DTT
Rnd1 (plexin
RBD bound)
Rnd1-GTP [17,18] residues 5-200, His6-tag
(cleaved after purification)
1 mM and vars.
ratios
25°C 50 mM Na.phosphate buffer (pH 6.8),
50 mM NaCl, 1 mM DTT, 5mM MgCl2
Rnd1 Rnd1-GMPPNP
[this report]
residues 5-200, W66L mutant,
His6-tag (cleaved after
purification)
0.54 mM 25°C 20 mM Tris-HCl (pH 7.0), 50 mM NaCl,
1.0 mM TCEP, 4 mM MgCl2, 0.01% NaN3
Full length proteins are Cdc42 (res. 1-191), Rac1 (res. 1-191), RhoA (res. 1-210), Rnd1 (1-223); 1 mM DTT was used in lysis buffer
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presented a strategy for the selection of sites to be mutated that
only relied on NMR and sequence data.
31 However, here the
crystal structure of a dimeric form of Rnd1 is available and guided
our approach. After optimization, a well behaved Rnd1 protein
was obtained in solution and the NMR spectrum was remarkably
improved compared with the spectra before optimization.
Importantly, ITC measurements showed that the mutant protein
retains binding affinity for one of its binding partners, the plexin-
B1 Rho GTPase binding domain. Successful optimization and
stabilization of Rnd1 achieved here forms a basis for future
detailed structural, dynamical and functional investigations in
solution by NMR. It also provides a useful guide for the study of
other Rho GTPase proteins.
Materials and Methods
His tagged Rnd1 protein expression, purification. The plasmid
encoding the Rnd1 GTPase (residues 5–200) was a gift from Dr.
Declan Doyle, formerly at the Structural Genomics Consortium
at Oxford. The gene had been PCR-amplified and inserted into
the pLIC-SGC1 vector (similar to pet15 of Invitrogen). Mutants
were made using the QuikChange Lightning site directed
mutagenesis kit (Agilent). Plasmids were transformed into E. coli
BL21 cells, which were inoculated in 5 ml LB (Lysogeny Broth)
medium at 37°C and subsequently grown in 0.8 L LB containing
1mM ampicillin at 37°C. When the cell culture reached an
OD600 of 0.6–0.8, protein expression was induced with 1 mM
IPTG (Isopropyl β-D-1-thiogalactopyranoside) at 25°C over-
night. Induced cells were harvested, centrifuged at 4,500 G for
20 min at 4°C. The pellets were re-suspended to 25 ml in Tris
buffer (20 mM Tris-HCl, 500 mM NaCl, 1.0 mM TCEP (Tris
(2-carboxyethyl)phosphine hydrochloride), 4.0 mM MgCl2,
pH 8.0). Just before sonication, standard protease inhibitors
were added. Following sonication, lysates were centrifuged at
30,000 G for 30 min at 4°C. The protein was purified from the
supernatant by use of 1 ml of Ni-NTA Agarose (Qiagen) beads.
Following 2 h of binding at 4°C, the beads were washed twice for
20 min with a buffer containing 20 mM TRIS-HCl, 500 mM
NaCl, 30 mM imidazole, 1.0 mM TCEP, 4 mM MgCl2, pH 7.5.
Proteins were eluted from beads using 5 mL elution buffer
containing 20 mM Tris-HCl, 500 mM NaCl, 500 mM
imidazole, 1.0 mM TCEP, 4 mM MgCl2, pH 7.5. The purity
of proteins was judged by 10% SDS-PAGE (sodium dodecyl
sulfate polyacrylamide gel electrophoresis).
15N uniformly labeled
proteins were expressed in E. coli BL21 grown in M9 media.
15,33
NH4Cl and
13CD 6-glucose was included as the sole nitrogen
and carbon source respectively. Partial deuteration of the protein
was accomplished by growing the bacteria in medium as above,
but where H2O was replaced by 100% D2O.
His tag cleavage from the Rnd1 protein. The construct
expressing tobacco etch virus protease (TEV) was purchased from
ACC (order number MBA-145). Expression and purification of
TEV protein followed an established protocol.
34 After purifica-
tion, both TEV and His tagged Rnd1 were dialyzed into a buffer
suitable for cleavage, consisting of 20 mM Tris-HCl, 500 mM
NaCl, 10 mM imidazole, 1.0 mM TCEP, 4 mM MgCl2, pH 7.5.
Then the TEV protease was mixed with His tagged Rnd1 at a
molar ratio of 1:4 (TEV/Rnd1) and 8% (v/v) glycerol was added.
After gentle rocking for 14–15 h at 4°C, the solution was loaded
to Ni-NTA Agarose (Qiagen) beads. This binding was performed
for 30 min to remove TEV and partially undigested Rnd1; then
the slurry was briefly centrifuged at 4°C, leaving the untagged
Rnd1 in the supernatant. The efficiency of cleavage was
monitored using SDS-PAGE to be . 90%.
NMR measurements. NMR experiments were performed at
298K on a Bruker Avance 800 MHz spectrometer equipped with
a TXI cryoprobe. Samples were prepared in the buffer at pH 7.0
containing 20 mM Tris-HCl, 1.0 mM TCEP, 50 mM NaCl,
4 mM MgCl2, 0.01% NaN3 and 10% D2O. The concentrations
of proteins for HN-TROSY experiments were 250 mM.
Concentrations of proteins for the 3D HNCO experiment were
540 mM. All data were processed with NMRPipe
35 and analyzed
with the program Sparky.
36
Calorimetric measurements. Calorimetric measurements of
binding between Rnd1 and an effector protein, plexin-B1 RBD,
were performed using an isothermal titration microcalorimeter
(VP-ITC, MicroCal). Both the proteins were exchanged with
identical buffer prior to the experiment using dialysis in phosphate
buffer, pH 7.0 composed of 50 mM NaCl, 4 mM MgCl2, and
1 mM TCEP. Isothermal titration calorimetry (ITC) measure-
ments were performed at 25°C. Rnd1 was placed into a
temperature controlled cell (volume 0.20 mL) and the second
protein plexin-B1 was placed into a syringe (capacity 0.04 mL) for
injection into the cell. The concentration of Rnd1 was 40 mM and
the concentration of plexin-B1 was 400 mM. The data were
analyzed using Origin software package supplied by MicroCal. An
offset due to a small dilution effect is constant and was subtracted.
Based on the concentrations of the titrant and the sample, the
software used a nonlinear least-squares algorithm to fit the series
of heat flows to an equilibrium binding equation. The best fit was
optimized, providing values for the stoichiometry (molar ratio) of
the interaction (N), enthalpy of binding (DH) and binary
equilibrium binding constant Ka [Ka = 1/Kd which is equal to
(Rnd1.Plexin) / (GTPase) x (Plexin)]. The free energy of binding
(DG) is determined from the well-known equation, DG = -2.303
RT log Ka and the entropy change (DS) upon binding is
determined using Gibbs-Helmholtz equation, DG=DH–TDS.
Results and Discussion
High yield expression and purification of His tagged Rnd1
protein. Well expressed and highly purified proteins are
important for in vitro studies of protein structure and dynamics.
Solution NMR usually requires concentrations in the 0.2–
1.0 mM range at volumes of 0.2–0.5 mL. Here, we expressed
recombinant N-terminally His tagged Rnd1 in E. coli bacteria
in both LB and M9 medium supplemented with
15NH4Cl. A
relatively large volume of buffer (5 mL) was used for elution from
Ni-NTA beads in order to avoid high concentrations of the
protein since the protein was more prone to aggregation with the
His tag. In total, 5 ml of unlabeled and 2 ml
15N labeled proteins
were produced at 200 mM concentration after purification from
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0.8 L of E. coli. The purity of protein was greater than 95% as
analyzed by SDS-PAGE. Both yield and purity of Rnd1 was
adequate and appeared favorable for NMR studies (~12 mg/L for
15N labeled and ~5 mg/L for
15N,
13C and for
2H,
15N,
13C labeled
protein).
Optimization of solution conditions. The dispersion of amide
signals in the 2D HN-TROSY NMR spectrum of Rnd1-His is
as would be expected for a well folded protein (several resonances
are seen at 10 ppm, others are seen down to 7 pm, Fig.1).
However, an uneven distribution of peak intensities and signal
line widths were observed and many resonances appear to be
missing; less than half of the expected 208 signals—main chain
amides and NH2 side chains- are seen (the total number of signals
is calculated as 196 amides, i.e., 208 residues—13 Prolines—1
N-terminus + 2 Trp side chain NH + 3 Asn NH2 + 9 Gln NH2).
Some of the strongest peaks are likely to arise from an overlapping
of resonances from residues, which have identical chemical
environments. Broad lines can arise from intermediate internal
protein dynamics, as well as from an exchange between monomers
and dimers or higher order oligomers.
37,38 Beyond this transient
aggregation, a considerable precipitation (approx. 40% of total
protein) was seen at the bottom of NMR tube after 2–3da t
25°C. Accordingly, repeat spectra recorded after this time showed
that NMR signals were significantly diminished. These observa-
tions indicated that His tagged Rnd1 was unstable in solution,
possibly because of partial unfolding followed by oligomerization
and gradually by subsequent aggregation.
A number of solution NMR parameters may be optimized to
give a better spectra: temperature is the most easily changed
condition. A higher temperature leads to faster global protein
motion and typically improves spectral line widths, but may also
increase protein unfolding, and thus, aggregation. Depending on
pH (see below), higher temperature may cause line broadening
due to the exchange of solvent accessible amide hydrogens with
those of the solvent. Lower temperature has the opposite effects.
In the case of Rnd1, the protein is large enough so that additional
line width, due to lowering the temperature, is problematic. At
the same time, higher temperatures lead to increased aggregation
and precipitation (data not shown). Sample pH can be varied in
principle but amide hydrogen exchange (above pH ~7.5) and
proteins unfolding at extremes of pH are often complicating
factors. In the case of Rnd1, we wanted to stay near physiological
pH, as the purpose of the project was to study the protein’s
functional interactions with other binding partners. Buffer
conditions may be varied, e.g., buffer type and salt concentration.
In another study in our lab, on the Rnd1 homologous GTPase
Rac1 we found that a physiological buffer
39 offered advantages.
14
However, this was not the case for Rnd1 and the protein gave
very similar spectra in three different kinds of buffer: Tris-HCl
buffer, phosphate buffer and physiological buffer containing the
same sodium chloride concentration (data not shown). A typical
phosphate buffer was chosen. Cosolvents, such as structure
stabilizing TFE (2, 2, 2-Trifluoroethanol),
40 TMAO (trimethyl-
amine N-oxide)
41 or CHAPS (3-[(3-cholamidopropyl)dimethyl-
ammonio]-1-propanesulfonate)
42 may be added in small amounts
(, 5–10% v/v). There are some examples where these solvents
help to dissociate proteins but the effect of these solvents on
protein-protein interactions in general has not yet been
thoroughly investigated and these solvents did not improve
spectra of Rnd1 (data not shown).
Cleavage of His tag and addition of GMPPNP stabilize Rnd1.
Protein aggregation can critically affect protein conformation,
function and activity. Usually, His tags are thought to have a
negligible effect on protein structure and function. But, several
papers reported that His tags do have effects on occasion,
including on protein expression level, protein solubility and also
on protein binding with target proteins.
43,44 We thus hypothesized
that the His tag may promote the oligomerization, aggregation
and substantial instability of Rnd1. In our study, the pLIC-SGC1
vector used for Rnd1 expression has a His6 tag; this 22 residue N-
terminal expression tag also contains a TEV (tobacco etch virus)
protease cleavage site. Following the protocols described for this
protease,
34 the His tag was removed from the protein. The NMR
HN-TROSY spectrum was acquired (Fig.3A) and compared
with that of the His tagged protein (Fig.1). An increased number
of peaks was seen (approximately an additional 90 resonances)
upon tag removal. Especially the line width of some of the
more dispersed signals was improved. However, gradual precip-
itation continued to be a serious problem after several days at
room temperature. We further hypothesized that the aggregation/
precipitation may be due to thermodynamic instability of the
protein fold. Small GTPases are known to become unstable under
a range of circumstances that principally arise from the oxidation
Figure1. Two dimension HN-TROSY spectrum (24 scans) of N-terminally
His-tagged Rnd1 at 250 mM, 298K.
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of thiol containing side chains and the formation of inter and
intra molecular disulfides and/or from loss of nucleotide cofactor.
The former is prevented by inclusion of reducing agents, such
as 1 mM TCEP in our case. The latter is usually prevented
by inclusion of 4 mM MgCl2 in all buffers. The remaining
precipitation of the protein raises the possibility that Rnd1 slowly
hydrolyzes GTP to GDP over a long time at room temperature
and that the GDP bound state is aggregation prone (e.g., GDP
may be lost more easily than GTP from Rnd1). In order to
prevent both scenarios we added a non-hydrolysable analog,
GMPPNP at 0.5 mM concentration to the protein in the latter
stages of the purification (it was not possible to “load” Rnd1 with
nucleotide using a protocol that is typically employed for Rac1,
Cdc42 and RhoA—see section 3.7 for details). In structural
biology studies, this analog of GTP has become particularly
popular since long-term stability of the protein-nucleotide
complex is required in order to grow homogeneous crystals or
to obtain a single state of the protein.
45,46 Addition of GMPPNP
to the solution combats several potential mechanisms and did
result in a marked improvement in the long-term stability of
Rnd1 samples. Spectra of Rnd1 with GMPPNP added did not
change with time, suggesting that the exchange of GMPPNP for
GTP does not cause a significant perturbation to chemical shifts.
Point mutations to solubilize the protein and NMR charac-
terization of mutants. Although His tag cleavage and addition
of GMPPNP improved Rnd1 stability, nevertheless, the HN-
TROSY spectrum still showed crowded regions with broad
resonances, especially in the center area (Fig.3A). The broad
resonances are most likely due to transient protein association.
Protein-protein association interfaces are dominated by certain
residue types (Trp, Tyr and Arg).
47 Previously, we had proposed a
strategy for the selection of sites that when mutated may disrupt
the association.
31 However, this approach was devised for cases
where only NMR data and sequence information was available.
Recently, the crystal structure of Rnd1 was solved (pdb id: 2CLS),
showing that the protein is a dimer in the crystal lattice and we
could, therefore, use a structure based approach (see refs.48 and
49 for other examples). The dimerization interface is apparent in
the asymmetric unit of the crystal cell and is composed of both
non-polar and polar contacts. These mainly involve residues V46,
F47, E48, residues Y73, Y74, D75, N76, V77 and also aromatic
residue W66 (Fig.2A and B). Residues V46, F47, E48 are
located at the C-terminus of the GTPase switch I region and Y73,
Y74, D75, N76, V77 are located in the center of the switch II
region. Both switch I and II regions are crucial for interactions
and functions of most small GTPases. Thus, dimer formation, if
indeedphysiological, would opposethebiological function of Rnd1.
In ordertobetterstudy Rnd1insolution,wewantedtodesignpoint
mutations that would disrupt Rnd1 dimer formation.
Three representative mutants are discussed here: W66L, Y74S
and N76R. W66 is situated at the side of the Rnd1 dimer
interface, Y74 is located at the central part of the dimer interface,
and N76 is placed at one end of the dimer interface. W66
contributes to the hydrophobic interaction by stacking with the
aromatic ring of residue F47. It also forms Van der Waals
interactions with the side chain of nonpolar residue V77. Residues
W66, F47, V77 in one chain, and the same residues in the other
counterpart chain, together form a hydrophobic cavity (Fig.2B).
Mutation of W66 to L will greatly decrease this hydrophobic
interaction. According to the crystal structure, the hydroxyl group
of Y74 forms a hydrogen bond with the hydroxyl group of Y74
in the counterpart Rnd1. It also contributes to hydrophobic
interaction with its side chain being packed in a cluster of
aromatic rings: Y73, F47 in the same chain of the dimer and also
F47, Y73 in the other chain (Fig.2A). Mutation of Y74 to S will
diminish the hydrophobic interaction due to loss of the aromatic
ring. It may also cause a loss of a hydrogen bond to the side chain
hydroxyl due to the significant change in side chain length. The
second residue, N76 forms multiple hydrogen bonds with the F47
main chain carbonyl oxygen and the side chain oxygens of E48
(Fig.2A). When N76 is mutated to R, the residue can in
principle form a salt bridge and also more hydrogen bonds, but in
practice Arg has a longer side chain than Asn and this is likely to
lead to steric clashes.
In the future, we want to study the change in protein stability
and dynamics upon complex formation between Rnd1 and
binding partners, such as plexin Rho GTPase binding domains.
Thus, the mutations should not strongly interfere with the
binding of this effector. However, since much of the interface is
shared between Rnd1 dimerization and plexin Rho GTPase
binding, the structure of Rnd1 in complex with the Rho GTPase
binding domain of plexin-B1 (pdb id: 2REX) also guided our
choice of mutants. Specifically, in this structure W66 makes a
weak (distant) interaction across the interface with plexin-B1
RBD residue H1804 of RBD. Y74 makes no interaction with
RBD, while the N76 side chain NH2 group forms an H-bond
with main chain carbonyl of plexin-B1 RBD residue H1838. This
is, in a sense, a negative control as this interaction is likely to be
disrupted upon mutation to Arg.
Efficient expression and purification of mutants, and also TEV
digestion of the N-terminal His-tag, was possible to a similar level
as for the wild-type protein. HN-TROSY spectra were acquired
and compared with those of the wild-type Rnd1. Both mutants
W66L and Y74S, which were supposed to decrease the interaction
between two monomers in the dimer, showed better spectra than
wild-type Rnd1. A slight improvement of the crowded areas in the
wild-type spectrum was observed (Fig.3B and C). A close-up
Figure2. Dimerization interface of Rnd1 from the crystal structure
[pdb id: 2CLS]. Left panel, ribbon diagram of the structure shows
the binding interface, with major residues involved shown as sticks.
Magenta dashed lines indicate hydrogen bonds. Right panel, structure
of left panel was rotated 60° around the X axis to show more clearly
the interaction of W66 and the hydrophobic cavity.
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view revealed that the spectrum of W66L is better than that of
Y74S. Compared with Y74S, the W66L mutant is also a better
choice since it more severely changes the non-polar character
of the interface, which appears to be more critical for Rnd1
homodimerization than for binding to plexin-B1 RBD. Mutant
N76R, gave worse spectra than wild type (Fig.3D). Thus, the
Rnd1 mutant W66L was selected for further studies. His-tag
cleavage, addition of non-hydrolysable GTP analog, and the
Figure3. NMR HN-TROSY spectra of Rnd1 wild type and mutants, protein concentration 250 mM run for 24 scans at 298K. (A) Rnd1 wild type, (B) W66L,
(C) Y74S and (D) N76R.
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W66L residue change did not result in an appreciable change in
protein secondary structure or stability at low protein concentra-
tion (20 mM), as monitored by far UV Circular Dichroism (data
not shown). However, the combination of these measures nearly
completely abolished Rnd1 aggregation/precipitation at NMR
concentrations over long periods of time.
Binding between W66L Rnd1 and the plexin-B1 RBD. The
overall dispersion and position of the majority of resonances is not
affected by the W66L mutation, indicating that the mutation
does not appreciably perturb the structure of the protein (Fig.3A
and B). However, at the same time we need to ensure that the
mutation does not adversely affect the function of the protein.
One function of interest is the binding of Rnd1 to its effector, the
RhoGTPase Binding Domain (RBD) of plexin-B1 in this case,
which is easily studied by ITC measurements (as described in
Materials and Methods). ITC showed binding with a stoichi-
ometric ratio N of 0.98. Ka was calculated as 2.09x10
5 M
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(fitting error: 1.98x10
4), and Kd as 4.8 ± 0.5 mM( Fig.4). This
dissociation constant is comparable with binding between plexin-
B1 RBD and wild type Rnd1, with a Kd of 5.5 ± 0.4 mM.
18
However, the binding enthalpy and entropy contributions
are altered by the mutation. The interaction between Rnd1mt
W66L and plexin-B1 RBD showed an enthalpy change (DH) of
-3.9 ± 0.1 kcal/mol and an entropy change*temperature (TDS) of
3.4 ± 0.2 kcal/mol. This compares with a DH of -6.7 ±
0.3 kcal/mol and TDS of 0.5 ± 0.2 kcal/mol for the interaction
between wild-type Rnd1 and the plexin-B1 RBD. Thus, the
W66L mutation decreases the favorable enthalpy contribution to
binding (L66 is likely to form fewer contacts in the complex) but
increases the favorable entropy to binding, possibly because
hydrophobic surface area, previously sequestered in a dimeric
form, now becomes buried on a transition from monomer to
bound Rnd1. Binding of Rnd1 mutant W66L and plexin-B1
RBD was also studied by NMR techniques. A comparison of
HN-TROSY spectra of the free and bound Rnd1 protein is
shown in Figure5. A shift and/or intensity change of the
resonance indicates that the residues are affected by binding of
the Plexin effector domain.
Deuteration improved
13C resonance intensity and cross-
peaks. The development of heteronuclear triple resonance NMR
experiments, in conjunction with the enrichment of proteins with
NMR active
13C and
15N isotopes, has dramatically increased the
scope of the NMR method for structural studies of biological
macromolecules.
50 However, compared with proteins of a
molecular weight less than approximately 20 kDa, NMR of
larger proteins is still more challenging. This arises from multiple
aspects: crowded spectra due to a larger number of resonances and
broad lines/low resonance signal-intensity due to faster relaxation.
An attractive approach is the replacement of protons by deuterium
in order to decrease the efficiency of
13C relaxation due to their
attached
1H. The application of deuteration for protein assign-
ment and structure determination has been explored in several
Figure4. Binding between Rnd1 mutant W66L and Plexin-B1 RBD.
(A) Binding isotherm and (B) fitted data for the association from
isothermal titration calorimetry (ITC) in phosphate buffer pH 7.0 with
50 mM NaCl, 4 mM MgCl2, and 1 mM TCEP at 25°C.
Figure5. Superimposed NMR HN-TROSY spectra of Rnd1 mutant W66L
and its Plexin-B1 RBD bound state. Free form of Rnd1 mutant W66L
(black) and bound to Plexin-B1 RBD (red) in phosphate buffer pH 7.0
with 50 mM NaCl, 4 mM MgCl2 and 1 mM TCEP at 25°C.
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publications.
50-54 Results proposed that, while 100% deuteration
gives maximum sensitivity for backbone assignment experiments
HNCOCA and HNCA,
53,54 maximum sensitivity for side chain
assignment experiments were achieved with 50% deuteration.
52
For NOESY experiments, deuteration affects HN-HN, HN-HC
and HC-HC cross peaks in different ways,
55 but 50% is a useful
compromise. So 50% deuteration is an appropriate and useful
way for backbone and side chain assignments of proteins up to
30 kDa, while maintaining good signal intensity for
1H/
1H
NOEs.
In this study, first a 3D HNCO experiment was performed
with the
15N,
13C labeled protein. The signal to noise ratio was
poor and a large number of peaks were missing. We then switched
to the triple labeled protein. Labeling is accomplished by growing
the protein in 100% D2O with
1H-glucose. After growing in
D2O medium, amides that are accessible will be back-exchanged
to
1H when the protein is purified in normal aqueous solution.
For some highly stable proteins, unfolding and refolding pro-
tocols need to be employed to allow back-exchange and growing
protein with
2H-glucose is more preferable. For Rnd1 this is not
an issue since the protein is relatively unstable and undergoes
local and possibly transient global unfolding. In this way, many of
the normal NH-based experiments can be performed on triple-
labeled proteins. The incorporation percentage of deuterium was
estimated by mass spectroscopy, confirming that ~50% percent of
protons were deuterated. HNCO spectra were acquired for both
double labeled and triple labeled Rnd1 mutant W66L (Fig.6).
Significant improvement was observed after partial deuteration.
This result builds a robust basis for future studies of the Rnd1
GTPase by solution NMR.
Comparison with other solution NMR studies of Rho
GTPases and general guidelines. Only 3 of 22 Rho GTPases
have been extensively studied by NMR to date, suggesting the
possibility that study of the rarer and functionally refined
GTPases may be difficult in solution, as their stability could be
associated with particular environments. It is interesting to note,
that although the GTPases are thought to primarily function at
the plasma membrane (to which they are anchored by their
modified C-termini),
56 study of truncated forms has been
relatively straightforward for the near ubiquitous family members,
Cdc42, Rac1 and RhoA. These proteins can also exist in the
cytoplasm, where their lipidated tail requires protection by
RhoGDI proteins.
16,57 In the case of Rnd1, and likely many
other GTPases, protein association and precipitation in aqueous
environments is a major challenge, as we have illustrated.
Aggregation/precipitation is less of an issue for crystallography
(crystallization conditions are far from NMR solution conditions
and aggregation may in fact favor crystal formation), but for
NMR is a considerable problem since the experiments require
both high protein concentration and extended time periods for
data recording. For Rnd1, we were fortunate to have information
about the surfaces that appear to originate the aggregation and our
study could utilize a strategic mutation, W66L, to solubilize the
protein. Although this was the key change that makes further
study possible, it was combined with several other optimization
steps that appear to be general for Rho GTPases.
The patterns that emerge from Table 1 provide several
guidelines. (1) In almost all cases, GTPase fragments were used,
as the full length proteins are often less soluble. The flexible
termini also create strong and highly overlapping signals in the
spectra, which may interfere with the characterization of other
parts of the proteins. (2) The GTPases need to be kept under
conditions that stabilize their nucleotide bound state. Several
factors contributed. Temperature: even modestly elevated tem-
peratures can lead to transient/partial unfolding and once the
nucleotide is released the unfolding, at least for several Rho
GTPases appears to be irreversible.
58 Lower temperature broadens
NMR signals for proteins .15 kDa sufficiently to make studies
prohibitive. All temperatures in Table1 are between 15–30°C.
pH and salt concentration: both need to be optimized—in part
this is related to protein association, as even transient contacts can
lead to partial unfolding and loss of the nucleotide. The overall
stability of the protein is also a function of pH (and electrostatic
screening of unfavorable interactions). In general, the solution
conditions are close to the GTPases isoelectric points (pIs are 5.76
for Cdc42, 8.78 for Rac1, 5.83 for RhoA and 7.96 for Rnd1).
Reducing agents: except for low pH studies (i.e., for Cdc42),
where disulphide bond formation is inhibited, DTT or TCEP
(effective at a lower concentration and more stable with time)
needs to be added in order to avoid covalent cross-linking.
Especially when formed between proteins, thiol groups that are
easily accessible in the structure, can lead to aggregation/protein
precipitation. Stabilization by Mg
2+ and by nucleotide loading/
availability: nucleotide free Rho GTPases are generally prone to
aggregation/precipitation. It is known from decades of study of
Ras and Rho GTPases that the nucleotide bound state is stabilized
by Mg
2+. Thus, its inclusion is essential for GTPase stability.
Cdc42, Rac1 and RhoA GTPases were simply prepared in GDP
form by the addition of excess GDP to the lysis-buffer, elution
or final buffer. The intrinsic hydrolysis activity of the wild-type
GTPase is typically sufficient, in that by the time the protein is
extracted and purified from E. coli, hydrolysis of all GTP to GDP
has occurred. In order to obtain proteins in the active form, the
bound GDP was exchanged for a non-hydrolyzable GTP analog
(GMPPNP, GMPPCP or GTPcS) following a general protocol
59
with small variations. The Cdc42, Rac1 and RhoA GDP bound
proteins are placed at relatively low concentration (~100 mM) in a
Figure6. Comparison is shown between a representative region of
the 2D projection of HNCO experiments of the double labeled and triple
labeled proteins. (A)
15N and
13C double labeled Rnd1 W66L mutant;
(B)
15N,
13C, 50% deuterated Rnd1 W66L mutant.
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buffer containing the non-hydrolysable GTP analog at 10-fold
excess in the presence of 10 mM EDTA. Often a stabilizing agent,
such as 0.3 M ammonium sulfate, is added for this step to
solubilize the apo state of the GTPase. Alkaline phosphatase can
also be added for specific degradation of GDP before MgCl2 is
added to excess (say 50 mM) over the EDTA that is present. This
stops the reaction and secures the bound state. Unbound
nucleotides and unfolded/aggregated proteins are typically
removed by gel filtration, though it is generally advantageous to
keep not only good amounts of MgCl2, but also additional
nucleotides in solution. (3) Bound GTPases can be stabilized (or
destabilized) by their binding partners. The challenges of studying
isolated GTPases by solution NMR do not necessarily transfer to
their complexes with effector or regulatory proteins. A range of
behaviors has been observed. For example, in the case of the Rac1
constitutively active mutant. Q61L the protein slowly precipitates
at room temperature in phosphate buffer, whereas the complex
with the Rho GTPase binding domain of plexin-B1 is stable
over weeks at a protein molar ratio of 1:1. An extreme example
of GTPase stabilization is the nucleotide free state of RhoA,
which is unstable by itself but can be characterized when the
protein is bound to an exchange factor, the DH-PH module of
PDZRhoGEF.
21
Summary
The Rnd1 GTPase plays important roles in the regulation of
neurite outgrowth, dendrite development, and axon guidance.
But, so far the solution structure and dynamics of the protein has
not been determined. Obtaining a sufficient amount of protein,
and a well behaved protein, is the first requirement for solution
NMR studies. Rnd1, when expressed with an N-terminal His6-tag
could be purified efficiently with Ni-NTA beads to yield an
adequate amount of pure protein. However, Rnd1 was found
to be unstable due to aggregation and subsequent precipitation
at room temperature. Combined approaches, including His-tag
cleavage and addition of non-hydrolysable GMPPNP nucleotide,
increased the stability, and abolished protein aggregation and
precipitation. In order to prevent aggregation of the protein, a
point mutation W66L was made in the putative association
interface based on the dimeric crystal structure. This markedly
improved the NMR spectra. Further spectral improvement of
13C resonances was possible by random fractional deuteration,
in particular this made 3D NMR experiments that involve
carbon nuclei suitable for further studies. The strategies des-
cribed here are likely to be useful in overcoming problems
in other poorly behaving proteins, such as the many other
GTPases of the Rho family that have not been studied by NMR
to date.
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